DE60325051D1 - SUBSTITUIERTE 3-AMINO-THIENO(2,3-b)PYRIDINE-2-AMIDE UND HERSTELLUNGSVERFAHREN SOWIE DEREN VERWENDUNG - Google Patents

SUBSTITUIERTE 3-AMINO-THIENO(2,3-b)PYRIDINE-2-AMIDE UND HERSTELLUNGSVERFAHREN SOWIE DEREN VERWENDUNG

Info

Publication number: DE60325051D1
Authority: DE; Germany
Prior art keywords: thieno; pyridine; amide; amino; substituted
Prior art date: 2002-06-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60325051T

Other languages

English (en)

Inventor

Ch L Cywin

Z Chen

Jonathan Emeigh

R W Fleck

M Hao

E Hickey

W Liu

D R Marshall

Tina M Morwick

P Nemoto

R J Sorcek

S Sun

J Wu

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Boehringer Ingelheim Pharmaceuticals Inc

Original Assignee

Boehringer Ingelheim Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-06-06

Filing date

2003-06-03

Publication date

2009-01-15

2003-06-03 Application filed by Boehringer Ingelheim Pharmaceuticals Inc filed Critical Boehringer Ingelheim Pharmaceuticals Inc

2009-01-15 Application granted granted Critical

2009-01-15 Publication of DE60325051D1 publication Critical patent/DE60325051D1/de

2023-06-04 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/68—Polyesters containing atoms other than carbon, hydrogen and oxygen
- C08G63/695—Polyesters containing atoms other than carbon, hydrogen and oxygen containing silicon
- C08G63/6954—Polyesters containing atoms other than carbon, hydrogen and oxygen containing silicon derived from polxycarboxylic acids and polyhydroxy compounds
- C08G63/6956—Dicarboxylic acids and dihydroxy compounds
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/91—Polymers modified by chemical after-treatment
- C08G63/914—Polymers modified by chemical after-treatment derived from polycarboxylic acids and polyhydroxy compounds
- C08G63/916—Dicarboxylic acids and dihydroxy compounds

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Pulmonology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Polymers & Plastics (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Diabetes (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Toxicology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Transplantation (AREA)
Oncology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Psychiatry (AREA)

DE60325051T 2002-06-06 2003-06-03 SUBSTITUIERTE 3-AMINO-THIENO(2,3-b)PYRIDINE-2-AMIDE UND HERSTELLUNGSVERFAHREN SOWIE DEREN VERWENDUNG Expired - Lifetime DE60325051D1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US38631202P	2002-06-06	2002-06-06
US45786703P	2003-03-26	2003-03-26
PCT/US2003/017343 WO2003103661A1 (en)	2002-06-06	2003-06-03	SUBSTITUTED 3-AMINO-THIENO[2,3-b]PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES

Publications (1)

Publication Number	Publication Date
DE60325051D1 true DE60325051D1 (de)	2009-01-15

Family

ID=29739900

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60325051T Expired - Lifetime DE60325051D1 (de)	2002-06-06	2003-06-03	SUBSTITUIERTE 3-AMINO-THIENO(2,3-b)PYRIDINE-2-AMIDE UND HERSTELLUNGSVERFAHREN SOWIE DEREN VERWENDUNG

Country Status (26)

Country	Link
US (2)	US6964956B2 (de)
EP (2)	EP1513516B1 (de)
JP (2)	JP4364120B2 (de)
KR (1)	KR20050005548A (de)
CN (1)	CN100386329C (de)
AR (1)	AR040250A1 (de)
AT (1)	ATE415966T1 (de)
AU (1)	AU2003237330A1 (de)
BR (1)	BR0311605A (de)
CA (1)	CA2483890C (de)
DE (1)	DE60325051D1 (de)
DK (1)	DK1513516T3 (de)
EA (1)	EA008706B1 (de)
ES (1)	ES2318141T3 (de)
HR (1)	HRP20041154A2 (de)
IL (1)	IL164597A0 (de)
ME (2)	MEP53508A (de)
MX (1)	MXPA04011246A (de)
NO (1)	NO20044599L (de)
NZ (1)	NZ537394A (de)
PE (1)	PE20040539A1 (de)
PL (1)	PL373424A1 (de)
RS (1)	RS105204A (de)
TW (1)	TWI296927B (de)
UY (1)	UY27834A1 (de)
WO (1)	WO2003103661A1 (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7780785B2 (en)	2001-10-26	2010-08-24	Applied Materials, Inc.	Gas delivery apparatus for atomic layer deposition
AU2003237330A1 (en)	2002-06-06	2003-12-22	Boehringer Ingelheim Pharmaceuticals, Inc.	Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
GB0214268D0 (en) *	2002-06-20	2002-07-31	Celltech R&D Ltd	Chemical compounds
WO2004041285A1 (en) *	2002-10-31	2004-05-21	Amgen Inc.	Antiinflammation agents
WO2005012283A1 (en) *	2003-07-31	2005-02-10	Boehringer Ingelheim Pharmaceuticals, Inc.	Substituted benzothiophene compounds and uses thereof
US7291733B2 (en) *	2003-10-10	2007-11-06	Boehringer Ingelheim Pharmaceuticals, Inc.	Substituted tricyclic heterocycles and their uses
US7119102B2 (en) *	2003-12-05	2006-10-10	Boehringer Ingelheim Pharmaceuticals, Inc.	Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
AU2005233437A1 (en) *	2004-04-12	2005-10-27	Sankyo Company, Limited	Thienopyridine derivatives
RU2006142740A (ru) *	2004-05-04	2008-06-10	Ф.Хоффманн-Ля Рош Аг (Ch)	Тиенопиридазины в качестве ингибиторов ikk
KR100796965B1 (ko) *	2004-05-04	2008-01-22	에프. 호프만-라 로슈 아게	Ｉｋｋ 저해제로서의 티에노피리딘
WO2005110410A2 (en) *	2004-05-14	2005-11-24	Abbott Laboratories	Kinase inhibitors as therapeutic agents
CA2567166A1 (en) *	2004-05-19	2005-11-24	Solvay Pharmaceuticals Gmbh	Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions
US7598259B2 (en)	2004-06-15	2009-10-06	Schering Corporation	mGluR1 antagonists as therapeutic agents
JP2007277093A (ja) *	2004-06-21	2007-10-25	Astellas Pharma Inc	三環系化合物
TW200616967A (en)	2004-06-24	2006-06-01	Smithkline Beecham Corp	Novel indazole carboxamides and their use
PE20060748A1 (es)	2004-09-21	2006-10-01	Smithkline Beecham Corp	Derivados de indolcarboxamida como inhibidores de quinasa ikk2
EP1879899B1 (de) *	2004-12-09	2010-08-04	Xention Limited	Thienopyridinderivate als kaliumkanalinhibitoren
EP1681292A1 (de) *	2005-01-12	2006-07-19	IBFB Pharma GmbH	3-Amino-6-aryl(bzw.6-heteroaryl)-thieno¬2,3-b\|pyridin-2-carbonsäureamide, diese enthaltende pharmazeutische Zubereitungen und ihre Verwendung als Inhibitoren der TNFalpha-Freisetzung
EP1683799A1 (de) *	2005-01-12	2006-07-26	IBFB Pharma GmbH	3-Amino-6aryl(bzw.6-heteroaryl)-4-R²-thieno[2,3-b]pyridin-2-carbonsäureamide, diese enthaltende pharmazeutische Zubereitungen und deren Verwendung als Inhibitoren der TNFalpha-Freisetzung
WO2006074919A2 (de) *	2005-01-12	2006-07-20	Curacyte Discovery Gmbh	3 -AMINO- 6-ARYL (BZW.6-HETEROARYL) -THIENO [2 , 3-B] PYRIDIN-2-CARBONSÄUREAMIDE, DIESE ENTHALTENDE PHARMAZEUTISCHE ZUBEREITUNGEN UND IHRE VERWENDUNG ALS INHIBITOREN DER TNFα-FREISETZUNG
US7465742B2 (en) *	2005-02-11	2008-12-16	Huanming Chen	Heterocyclic compounds having anti-HBV activity
EP1908480A4 (de) *	2005-06-03	2009-07-01	Riken	Interferon-alpha-regulator
CN1884262B (zh) *	2005-06-24	2014-06-25	中国人民解放军军事医学科学院毒物药物研究所	4-氨基哌啶类化合物及其医药用途
AR055343A1 (es)	2005-06-30	2007-08-22	Smithkline Beecham Corp	Derivados de indolcarboxamida inhibidores de quinasas ikk2
US8063071B2 (en)	2007-10-31	2011-11-22	GlaxoSmithKline, LLC	Chemical compounds
PE20070619A1 (es) *	2005-09-27	2007-07-02	Wyeth Corp	TIENO(2,3-b)PIRIDIN-5-CARBONITRILOS COMO INHIBIDORES DE PROTEINAS QUINASA
WO2007043581A1 (ja) *	2005-10-12	2007-04-19	Daiichi Sankyo Company, Limited	チエノピリジン－２－カルボキサミド誘導体
WO2007102679A1 (en) *	2006-03-06	2007-09-13	Je Il Pharmaceutical Co., Ltd.	Novel thienopyrimidine derivatives or pharmaceutically acceptable salts thereof, process for the preparation thereof and pharmaceutical composition comprising the same
WO2007146602A1 (en) *	2006-06-06	2007-12-21	Boehringer Ingelheim International Gmbh	Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxamide compounds, their preparation and use
US20080032409A1 (en) *	2006-08-07	2008-02-07	California Institute Of Technology	Fluorescent biomolecule labeling reagents
WO2008020622A1 (en) *	2006-08-17	2008-02-21	Kyorin Pharmaceutical Co., Ltd.	NOVEL THIENO[2,3-d]PYRIMIDINE COMPOUND
PE20081889A1 (es)	2007-03-23	2009-03-05	Smithkline Beecham Corp	Indol carboxamidas como inhibidores de ikk2
CN101684123B (zh) *	2008-09-27	2013-12-11	四川大学	2-甲酰胺基噻吩并吡啶衍生物制备方法及医药用途
US8354539B2 (en)	2009-03-10	2013-01-15	Glaxo Group Limited	Indole derivatives as IKK2 inhibitors
US8481547B2 (en) *	2009-12-18	2013-07-09	Janssen Pharmaceutica Nv	Substituted benzothiazole and benzoxazole derivatives useful as inhibitors of DPP-1
US10531655B2 (en)	2011-12-02	2020-01-14	The Regents Of The University Of California	Reperfusion protection solution and uses thereof
RS55388B1 (sr) *	2012-02-09	2017-03-31	Merck Patent Gmbh	Furo[3, 2 - b]piridin derivati kao tbk1 i ikk inhibitori
KR101468207B1 (ko) *	2013-02-14	2014-12-01	한국화학연구원	신규한 싸이에노[3,2-b]피리딜 우레아 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 유로텐신-Ⅱ 수용체 활성 관련 질환의 예방 또는 치료용 약학적 조성물
WO2015091645A1 (en)	2013-12-18	2015-06-25	Basf Se	Azole compounds carrying an imine-derived substituent
RU2557550C1 (ru) *	2014-06-16	2015-07-27	Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный аграрный университет"	Антидот гербицида 2,4-дихлорфеноксиуксусной кислоты на подсолнечнике
EP3302468A4 (de) *	2015-06-01	2019-02-06	The Scripps Research Institute	Kleinmolekülige analoge des nemo-bindenden peptids
KR20180073600A (ko) *	2015-11-03	2018-07-02	루 라이센스 에이비	과증식성 장애의 치료를 위한 화합물
TWI753910B (zh) *	2016-05-16	2022-02-01	美商拜歐斯瑞克斯公司	吡啶硫酮、其醫藥組合物及其治療增生性、炎性、神經退化性或免疫介導疾病之治療用途
EP3801511A1 (de) *	2018-06-06	2021-04-14	Institut National De La Sante Et De La Recherche Medicale - Inserm	Thieno[2,3-b]pyridin-derivate als epac-inhibitoren und deren pharmazeutische verwendungen
US12281080B2 (en)	2018-08-21	2025-04-22	University Of South Carolina	Quinoline-based compounds and methods of inhibiting CDK8/19
US11014906B2 (en)	2018-08-21	2021-05-25	University Of South Carolina	Quinoline-based compounds and methods of inhibiting CDK8/19
CA3128377A1 (en)	2019-02-01	2020-08-06	University Of South Carolina	Bicyclic pyridine compositions and methods of using the same for cancer therapy
WO2020237014A1 (en) *	2019-05-21	2020-11-26	University Of South Carolina	3-amino-4-(4-(4 (dimethylcarbamoyl) phenyl)-1,4-diazepan-1-yl) thieno [2,3-b] pyridine-2-carboxamide for use in cancer therapy and formulations comprising the same
CN113248353B (zh) *	2021-07-01	2022-02-25	山东国邦药业有限公司	一种2,4-二氯-5-氟苯乙酮的制备方法
CN115725987B (zh) *	2021-08-31	2025-04-29	赤壁市高质量发展研究院有限公司	一种4-吡啶甲醇的制备方法
CN115716802A (zh) *	2022-10-20	2023-02-28	山西永津集团有限公司	一种4-溴-2-氯烟腈的合成方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS50140487A (de) *	1974-04-15	1975-11-11
WO1992003427A1 (fr)	1990-08-17	1992-03-05	Yoshitomi Pharmaceutical Industries, Ltd.	Compose de cetone et remede pour l'osteoporose
US5852046A (en) *	1993-08-03	1998-12-22	Hoechst Aktiengesellschaft	Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them
JP3254843B2 (ja) *	1993-08-09	2002-02-12	三菱ウェルファーマ株式会社	新規縮合ヘテロ環誘導体
US5350748A (en) *	1993-08-18	1994-09-27	Warner-Lambert Company	3-thio or amino substituted-benzo[b]thiophene-2-carboxamides and 3-oxygen, thio, or amino substituted-benzofuran-2-carboxamides as inhibitors of cell adhesion
DE4420922A1 (de)	1994-06-16	1995-12-21	Bayer Ag	Verfahren zur Herstellung von Benzothiophenderivaten
US5656638A (en)	1995-04-18	1997-08-12	Geron Corporation	Telomerase inhibitors
US6313301B1 (en)	1997-08-13	2001-11-06	Takeda Chemical Industries, Ltd.	Thienopyridine derivatives, their intermediates and production thereof
US6232320B1 (en)	1998-06-04	2001-05-15	Abbott Laboratories	Cell adhesion-inhibiting antiinflammatory compounds
WO2000005234A1 (en) *	1998-07-22	2000-02-03	Suntory Limited	NF-λB INHIBITORS CONTAINING INDAN DERIVATIVES AS THE ACTIVE INGREDIENT
TW564247B (en)	1999-04-08	2003-12-01	Akzo Nobel Nv	Bicyclic heteraromatic compound
WO2000075145A1 (en)	1999-06-03	2000-12-14	Abbott Laboratories	Cell adhesion-inhibiting antiinflammatory compounds
DE50010931D1 (de) *	1999-06-23	2005-09-15	Aventis Pharma Gmbh	Substituierte benzimidazole
DE19951360A1 (de)	1999-10-26	2001-05-03	Aventis Pharma Gmbh	Substituierte Indole
GB0003154D0 (en)	2000-02-12	2000-04-05	Astrazeneca Uk Ltd	Novel compounds
EP1268477B1 (de)	2000-03-15	2010-04-21	Sanofi-Aventis Deutschland GmbH	Substituierte beta-carboline mit ikb-kinase hemmender wirkung
KR100774855B1 (ko) *	2000-04-27	2007-11-08	아스텔라스세이야쿠 가부시키가이샤	축합 헤테로아릴 유도체
DE60106022T2 (de) *	2000-06-06	2006-03-09	Pfizer Products Inc., Groton	Thiophenverbindungen zur verwendung als antikrebsmittel
MXPA03003599A (es)	2000-10-26	2003-08-01	Tularik Inc	Agentes antiinflamatorios.
EP1417315A2 (de)	2001-07-20	2004-05-12	Emerald Bioagriculture Corporation	Pflanzliche ionenkanäle und verfahren
BR0213734A (pt)	2001-10-30	2004-10-19	Pharmacia Corp	Derivados de carboxamida heteroaromático para o tratamento de inflamação
US6974870B2 (en) *	2002-06-06	2005-12-13	Boehringer Ingelheim Phamaceuticals, Inc.	Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
AU2003237330A1 (en) *	2002-06-06	2003-12-22	Boehringer Ingelheim Pharmaceuticals, Inc.	Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
WO2005001849A1 (fr)	2003-06-27	2005-01-06	Eremeev, Petr Igorevich	Procede de prise en charge du combustible nucleaire epuise
WO2005012283A1 (en) *	2003-07-31	2005-02-10	Boehringer Ingelheim Pharmaceuticals, Inc.	Substituted benzothiophene compounds and uses thereof
US7291733B2 (en) *	2003-10-10	2007-11-06	Boehringer Ingelheim Pharmaceuticals, Inc.	Substituted tricyclic heterocycles and their uses
US7119102B2 (en) *	2003-12-05	2006-10-10	Boehringer Ingelheim Pharmaceuticals, Inc.	Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
JP2005194198A (ja)	2003-12-26	2005-07-21	Takeda Chem Ind Ltd	チエノピリジン化合物
NZ553329A (en) *	2004-07-22	2010-09-30	Ptc Therapeutics Inc	Thienopyridines for treating hepatitis C
GB0420719D0 (en)	2004-09-17	2004-10-20	Addex Pharmaceuticals Sa	Novel allosteric modulators
MX2007004783A (es)	2004-10-21	2007-05-11	Pfizer	Inhibidores de la proteasa del virus de la hepatitis c, y composiciones y tratamientos que los usan.
US20060293709A1 (en)	2005-06-24	2006-12-28	Bojarski Raymond A	Tissue repair device

2003
- 2003-06-03 AU AU2003237330A patent/AU2003237330A1/en not_active Abandoned
- 2003-06-03 BR BR0311605-0A patent/BR0311605A/pt not_active IP Right Cessation
- 2003-06-03 MX MXPA04011246A patent/MXPA04011246A/es not_active Application Discontinuation
- 2003-06-03 US US10/453,175 patent/US6964956B2/en not_active Expired - Lifetime
- 2003-06-03 RS YU105204A patent/RS105204A/sr unknown
- 2003-06-03 CA CA2483890A patent/CA2483890C/en not_active Expired - Fee Related
- 2003-06-03 KR KR10-2004-7019850A patent/KR20050005548A/ko not_active Ceased
- 2003-06-03 EA EA200401541A patent/EA008706B1/ru not_active IP Right Cessation
- 2003-06-03 ME MEP-535/08A patent/MEP53508A/xx unknown
- 2003-06-03 WO PCT/US2003/017343 patent/WO2003103661A1/en not_active Ceased
- 2003-06-03 NZ NZ537394A patent/NZ537394A/en unknown
- 2003-06-03 AT AT03736796T patent/ATE415966T1/de active
- 2003-06-03 DE DE60325051T patent/DE60325051D1/de not_active Expired - Lifetime
- 2003-06-03 ES ES03736796T patent/ES2318141T3/es not_active Expired - Lifetime
- 2003-06-03 EP EP03736796A patent/EP1513516B1/de not_active Expired - Lifetime
- 2003-06-03 UY UY27834A patent/UY27834A1/es not_active Application Discontinuation
- 2003-06-03 ME MEP-2008-535A patent/ME00355B/me unknown
- 2003-06-03 EP EP08164478A patent/EP2008654A1/de not_active Withdrawn
- 2003-06-03 CN CNB038099586A patent/CN100386329C/zh not_active Expired - Fee Related
- 2003-06-03 JP JP2004510780A patent/JP4364120B2/ja not_active Expired - Fee Related
- 2003-06-03 DK DK03736796T patent/DK1513516T3/da active
- 2003-06-03 HR HR20041154A patent/HRP20041154A2/hr not_active Application Discontinuation
- 2003-06-03 PL PL03373424A patent/PL373424A1/xx not_active Application Discontinuation
- 2003-06-04 PE PE2003000560A patent/PE20040539A1/es not_active Application Discontinuation
- 2003-06-05 TW TW092115243A patent/TWI296927B/zh active
- 2003-06-06 AR ARP030102022A patent/AR040250A1/es unknown
2004
- 2004-10-14 IL IL16459704A patent/IL164597A0/xx unknown
- 2004-10-25 NO NO20044599A patent/NO20044599L/no not_active Application Discontinuation
2005
- 2005-08-18 US US11/206,707 patent/US7405225B2/en not_active Expired - Lifetime
2009
- 2009-02-18 JP JP2009035787A patent/JP2009102447A/ja active Pending

Also Published As

Publication number	Publication date
HRP20041154A2 (en)	2005-06-30
KR20050005548A (ko)	2005-01-13
ATE415966T1 (de)	2008-12-15
ES2318141T3 (es)	2009-05-01
JP2005530816A (ja)	2005-10-13
DK1513516T3 (da)	2009-10-19
US6964956B2 (en)	2005-11-15
US20040053957A1 (en)	2004-03-18
TW200401640A (en)	2004-02-01
TWI296927B (en)	2008-05-21
CN100386329C (zh)	2008-05-07
CA2483890C (en)	2012-12-11
US7405225B2 (en)	2008-07-29
US20050288285A1 (en)	2005-12-29
EA200401541A1 (ru)	2005-06-30
EP2008654A1 (de)	2008-12-31
RS105204A (sr)	2006-12-15
JP4364120B2 (ja)	2009-11-11
AU2003237330A1 (en)	2003-12-22
MXPA04011246A (es)	2005-06-03
EA008706B1 (ru)	2007-06-29
BR0311605A (pt)	2005-02-22
EP1513516B1 (de)	2008-12-03
CA2483890A1 (en)	2003-12-18
WO2003103661A1 (en)	2003-12-18
MEP53508A (en)	2011-05-10
JP2009102447A (ja)	2009-05-14
IL164597A0 (en)	2005-12-18
UY27834A1 (es)	2003-12-31
HK1080737A1 (zh)	2006-05-04
ME00355B (me)	2010-06-30
EP1513516A1 (de)	2005-03-16
NO20044599L (no)	2005-02-16
AR040250A1 (es)	2005-03-23
PE20040539A1 (es)	2004-10-21
NZ537394A (en)	2006-12-22
CN1649581A (zh)	2005-08-03
PL373424A1 (en)	2005-08-22

Publication	Publication Date	Title
DE60325051D1 (de)	2009-01-15	SUBSTITUIERTE 3-AMINO-THIENO(2,3-b)PYRIDINE-2-AMIDE UND HERSTELLUNGSVERFAHREN SOWIE DEREN VERWENDUNG
DE60205555D1 (de)	2005-09-22	Fluorinierte cycloolefinpolymere und verfahren zu deren herstellung, sowie deren verwendung
FR2838429B1 (fr)	2004-12-17	Plaque vitroceramique et son procede de fabrication
EP1488920A4 (de)	2008-08-27	Gipsplatte und verfahren zur herstellung der gipsplatte
DE60132450D1 (de)	2008-03-06	Solarzelle und Herstellungsmethode
EP1150659A4 (de)	2005-03-30	Geformte anorganische körper, deren herstellungsverfahren und verwendung
ATE476412T1 (de)	2010-08-15	Acyl-4-carboxy-phenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung
DE60034683D1 (de)	2007-06-14	3(5)-ureido-pyrazolderivate, deren herstellungsverfahren und verwendung als krebshemmende mittel
DE60311063D1 (de)	2007-02-22	Ausziehleiter und zugehörige herstellungsverfahren
FR2841631B1 (fr)	2007-04-13	Structure de raccord de tuyau et son procede de fabrication
EP1516845A4 (de)	2008-12-03	Seil für aufzug und verfahren zur herstellung des seils
DE60235547D1 (de)	2010-04-15	En daraus, deren herstellung und verwendung
FR2837217B1 (fr)	2006-11-24	Revetement composite de mosi2-si3n4 et son procede de fabrication
IL166467A0 (en)	2006-01-15	Auto-stimulating cells and method for making and using the same
EP1357611A4 (de)	2010-04-28	Piezoelektrisches funktionsteil und verfahren zur herstellung des teils
DE60223761D1 (de)	2008-01-10	Polierzusammensetzung und Polierverfahren unter deren Verwendung
FR2842443B1 (fr)	2005-02-11	Plaque metallique, son procede de fabrication et son procede de pliage
FR2836243B1 (fr)	2005-01-28	Ecran de retroprojection et son procede de fabrication
EP1536484A4 (de)	2009-01-07	Organisches halbleiterbauelement und verfahren zu seiner herstellung
DE50312828D1 (de)	2010-08-05	Bitleitungsstruktur sowie verfahren zu deren herstellung
DE60325087D1 (de)	2009-01-15	Tetrafluorethylencopolymer, herstellungsverfahren dafür und pastenextrudat
DE60306074D1 (de)	2006-07-27	Mikrokapsel sowie Herstellungsverfahren
DE60227139D1 (de)	2008-07-31	Halbleiter-IC-Module, Herstellungsmethode und Verwendung
EP1563974A4 (de)	2008-02-20	Prepreg und herstellungsverfahren dafür
DE50310363D1 (de)	2008-10-02	Blaue 3h-naphtho 2,1-b -pyran-derivate sowie deren verwendung

Legal Events

Date	Code	Title	Description
2009-12-24	8364	No opposition during term of opposition